Open company graph database — free web & API
Login

Taiko Pharmaceutical Co., Ltd.

大幸薬品株式会社
Ticker
Listed market
TYO
Country
Japan
Employees (consolidated)
220
Related companies
8
§01

Basic information

BASIC
Head office
1-4-1 Nishi-Hommachi, Nishi-ku, Osaka, Osaka 550-0005, Japan
Chief executive
Takashi Shibata
Capital
10,000,000
Employees (non-consolidated)
193 people
Employees (consolidated)
220 people
Start date
1946-11-18
End date
§02

Websites

1 DOMAINS
§03

Business

3
Manufacture and sale of pharmaceuticalsManufacture and sale of daily-use productsManufacture and sale of infectious disease prevention products
§04

Related companies

8 COMPANIES
Company name Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder
Taiwan Da Xing Pharmaceutical Co., Ltd.
Group
Daiko TEC Corporation
Group
Daikou Pharmaceutical (Asia Pacific) Co., Ltd.
Group
Da Xing Pharmaceutical (Shenzhen) Co., Ltd.
Group
<台湾>
Group
<香港>
Group
社団法人日本二酸化塩素工業会
Customer
大幸薬品(香港)
Names without a link are companies not yet registered in OpenBizGraph
§05

Network

NETWORK
Drag to move · click to open
§06

History

75 EVENTS

July 1940: Otojiro Shibata founded Shibata Pharmaceutical Works in Suita, Osaka Prefecture.Sources

Shibata Onijiro founded Shibata Pharmaceutical in Suita City, Osaka Prefecture.Sources

1943: Following the merger of 10 companies, Shibata Pharmaceutical Works became the Fourth Plant of Taiyo Pharmaceutical.Sources

Shibata Pharmaceutical became the fourth factory of Taiyo Pharmaceutical through a joint venture of ten companies.Sources

April 1946: Acquired the manufacturing and sales rights for Chuyu Seirogan (now “Seirogan”) from Nakajima Saichi Pharmacy.Sources

Inherited the manufacturing and sales rights for Chūyū Seirōgan (now "Seirōgan") from Nakajima Saichi Pharmacy.Sources

November 1946: Became independent from Taiyo Pharmaceutical and established Taiho Pharmaceutical Co., Ltd. in Suita, Osaka Prefecture; began sales of Chuyu Seirogan.Sources

Established Daikō Pharmaceutical Co., Ltd. after separating from Taiyo Pharmaceutical and began selling Chūyū Seirōgan.Sources

Establishment date: November 18, 1946Sources

May 1954: Began exporting “Seirogan.”Sources

Started exporting "Seirōgan".Sources

April 1964: Opened the Tokyo Branch Office (now the Tokyo Office) in Ota-ku, Tokyo.Sources

Opened a Tokyo branch office (now Tokyo Office) in Ota Ward, Tokyo.Sources

October 1966: Began sales of “Seirogan Sugar-Coated Tablets.”Sources

Started selling "Seirōgan Sugar Coated".Sources

June 1972: Built the head office building and Suita Plant in Suita, Osaka Prefecture.Sources

Constructed a headquarters building and a Suita factory in Suita City, Osaka Prefecture.Sources

June 1979: Renovated the Suita Plant, bringing it into compliance with GMP.Sources

Renovated the Suita factory to become a GMP-compliant facility.Sources

November 1981: Began sales of “Seirogan Sugar-Coated Tablets A.”Sources

Started selling "Seirōgan Sugar Coated A".Sources

November 1990: Opened the Nagoya Branch Office (now the Nagoya Office) in Meito-ku, Nagoya, Aichi Prefecture.Sources

Opened a Nagoya branch office (now Nagoya Office) in Meito Ward, Nagoya City, Aichi Prefecture.Sources

November 1991: Built a research building in Suita, Osaka Prefecture, to enhance basic research.Sources

Built a research building in Suita City, Osaka Prefecture to further enhance basic research.Sources

March 1992: Established Taiho Creosote Co., Ltd. in Suita, Osaka Prefecture, to manufacture wood creosote, the main ingredient in “Seirogan.”Sources

Established Daikō Creosote Co., Ltd. in Suita City, Osaka Prefecture to produce the main raw material, Japanese cedar creosote.Sources

December 1996: Established Taiho Pharmaceutical Co., Ltd. in Taiwan to strengthen pharmaceutical sales in the Taiwanese market.Sources

Established Daikō Pharmaceutical Co., Ltd. (Taiwan) to strengthen pharmaceutical sales in the Taiwanese market.Sources

February 1997: Opened a Shenzhen office in China to conduct market research and collect pharmaceutical regulatory information.Sources

Established a Shenzhen office in China for market research and regulatory information gathering.Sources

November 2004: Established Taiho Pharmaceutical (Asia Pacific) Co., Ltd. in Hong Kong to strengthen sales.Sources

Established Daikō Pharmaceutical (Asia Pacific) Ltd. in Hong Kong.Sources

February 2005: Established Seirogan (International) Co., Ltd. to protect the “Seirogan” trademark in China, centered on Hong Kong.Sources

Established Seirōgan (International) Ltd. in Hong Kong to protect the trademark of "Seirōgan" in China.Sources

April 2005: Started selling hygiene management product 'Krevelin'.Sources

Started selling hygiene product "Kurebin".Sources

November 2005: To promote infection control business, acquired Shanghai Anbu Environmental Technology Co., Ltd. as a subsidiary and renamed it Daikyou Anbu Environmental Technology (Shanghai) Co., Ltd.Sources

Acquired Ab Environmental Technology (Shanghai) Co., Ltd. and renamed it Daikō Ab Environmental Technology (Shanghai) Ltd. to promote infection control business.Sources

March 2006: For expanding the infection control business, absorbed Business Plan Co., Ltd., which owns related patents.Sources

Acquired and merged with Business Plan Co., Ltd., which owns related patents, to expand the infection control business.Sources

March 2009: Listed shares on the Second Section of the Tokyo Stock Exchange.Sources

Listed on the Second Section of the Tokyo Stock ExchangeSources

April 2010: Designated to the First Section of the Tokyo Stock Exchange.Sources

Designated on the First Section of the Tokyo Stock ExchangeSources

December 2011: Moved Tokyo office to Minato-ku, Tokyo.Sources

Relocated Tokyo office to Minato-ku, TokyoSources

February 2012: Established Taiwan branch and transferred operations from Daikyou Pharmaceutical Co., Ltd.Sources

Established a Taiwan branch and transferred operations from Da Xing Pharmaceutical Co., Ltd.Sources

March 2013: Moved Nagoya office to Naka-ku, Nagoya, Aichi Prefecture.Sources

Relocated Nagoya office to Nakanuma-ku, Nagoya City, Aichi PrefectureSources

March 2014: Moved headquarters functions to Nishi-ku, Osaka, Osaka Prefecture.Sources

Relocated headquarters functions to Nishi-ku, Osaka City, Osaka PrefectureSources

August 2015: Established Kyoto factory and R&D center in Sekka-cho, Sagarakuni, Kyoto Prefecture.Sources

Established Kyoto factory and R&D center in Sekka-cho, Sōraku-gun, Kyoto PrefectureSources

April 2017: Started selling 'Seirogan Quick C'.Sources

Started sales of "Seirogan Quick C"Sources

September 2019: Launched daily disinfection product brand 'Kreve & And'.Sources

Launched daily disinfectant product brand "Creve & And"Sources

April 2020: Established Taiwan Daikyou Pharmaceutical Co., Ltd. in Taiwan and acquired the local Krevelin distributor's web sales business.Sources

Established Taiwan Da Xing Pharmaceutical Co., Ltd. in Taiwan and acquired local Crevelin sales agency web businessSources

May 2020: To accelerate pharmaceutical and infection control business in China, established Daikyou Pharmaceutical (Shenzhen) Co., Ltd. in Shenzhen.Sources

Established Da Xing Pharmaceutical (Shenzhen) Co., Ltd. in Shenzhen, ChinaSources

October 2020: Established Daikyou Pharmaceutical International Co., Ltd. in Nishi-ku, Osaka, Osaka Prefecture.Sources

Established Da Xing Pharmaceutical International Co., Ltd. in Nishi-ku, Osaka City, Osaka PrefectureSources

November 2020: Established Ibaraki factory in Saicho, Ibaraki City, Osaka Prefecture.Sources

Established Ibaraki factory in Saicho, Ibaraki City, Osaka PrefectureSources

January 2021: Closed Shenzhen office and integrated into Daikyou Pharmaceutical (Shenzhen) Co., Ltd.Sources

Closed Shenzhen office and merged into Da Xing Pharmaceutical (Shenzhen) Co., Ltd.Sources

October 2021: Closed Taiwan branch and integrated operations into Taiwan Daikyou Pharmaceutical Co., Ltd.Sources

Closed Taiwan branch and integrated operations into Taiwan Da Xing Pharmaceutical Co., Ltd.Sources

April 2022: Moved to the new Prime Market of the Tokyo Stock Exchange.Sources

Transitioned to the Prime Market of the Tokyo Stock ExchangeSources

August 2023: Moved Tokyo office to Shibaura, Minato-ku, Tokyo.Sources

Relocated Tokyo office to Shibaura, Minato-ku, TokyoSources

§07

News

5 ARTICLES

Notice and Request from Daiko Pharmaceutical Co., Ltd.Sources

On May 27, 2026, Daiko Pharmaceutical issued a warning regarding products mistakenly sold through online shopping advertisements. The relevant products are from other companies and are not products of the company. They are cautioning customers to avoid misunderstandings.

Misconceptions and Warnings Regarding the Sale of SeiroganSources

Daikou Pharmaceutical clearly states that the product mistakenly identified as being sold by the 'Seirogan company' in online advertising is actually a product from another company and not their own. They also state that they cannot provide answers regarding that product in response to customer inquiries.

Taiko Pharmaceutical Announces Official Apparel Line and Eco-Friendly PackagingSources

Taiko Pharmaceutical released original T-shirts inspired by Seirogan and also changed to environmentally friendly packaging. Additionally, they donated disaster prevention whistles to an elementary school in Suita City, Osaka Prefecture, where the company was founded.

Daiko Pharmaceutical Media Information and Product IntroductionSources

As of April 1, 2020, Daiko Pharmaceutical was ranked first in the Kansai region's corporate market capitalization growth rate ranking. Multiple media outlets have introduced products and initiatives such as 'Kurebelling' and 'Kurebe & And,' responding to the increased demand for hygiene measures due to the impact of the novel pneumonia.

Daikou Pharmaceutical ranks first among Kansai companies in market capitalization growth rateSources

On April 1, 2020, the Osaka edition of the Nikkei newspaper reported that Daikou Pharmaceutical was ranked first in the 2019 market capitalization growth rate ranking among Kansai companies.

§08

Public records

GOV
National Tax Agency basic information2120901007344
Source: National Tax Agency Corporate Number Publication Site, basic three itemsSources
Trade name
大幸薬品株式会社
Trade name (kana)
タイコウヤクヒン
Name in English
Corporation type
301
Address
〒564-0032 大阪府吹田市内本町3丁目34番14号
Postal code
5640032
Prefecture code
27
City code
205
Address outside Japan
Prefecture in English
City in English
Address outside Japan in English
Corporate number assignment date
2015-10-05
Update date
2018-04-16
Change date
2015-10-05
Registry closure date
Reason for registry closure
Successor corporate number
Details of the change
Latest record
1
Excluded from search
0
Processing type
01
Correction type
1
Trade name image ID
Address image ID
Sequence number
4077459
METI gBizINFO2120901007344
Source: gBizINFO (Ministry of Economy, Trade and Industry)Sources
Corporate number
2120901007344
Trade name
大幸薬品株式会社
Trade name (kana)
タイコウヤクヒン
Trade name (alphabet)
Registry closure date
Reason for registry closure
Registered address
大阪府吹田市内本町3丁目34番14号
Postal code
5640032
Prefecture
大阪府
Prefecture code
27
City or district
吹田市
City code
205
Street address
内本町3丁目34番14号
Organisation type
301
Processing type
01
Correction type
1
Status
Representative
代表取締役社長  柴田 高
Capital
10000000
Employees
227
Employees (male)
117
Employees (female)
76
Business summary
Website URL
Year founded
Business category
E:製造業
Date established
Unified government qualification - grade
Unified government qualification - business items
Update date
2018-04-16
Key information
2120901007344
§09

Sources & updates

SOURCES
↑